APCOTEXIND.NS APCOTEXIND NSE
₹479.60
+30.88% 1Y
Market & Price
Market Cap
-
Current Price
₹479.60
High / Low (52W)
₹520.65 / ₹314.10
Beta
-
Valuation
Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
₹-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-
Profitability & Returns
ROCE
21.22%
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
₹6.70
EPS (TTM)
₹-
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
₹986.49 Cr
Current Assets
₹495.39 Cr
Working Capital
₹197.29 Cr
Ownership
Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Growth (CAGR)
Revenue 5Y
10.47%
Profit 5Y
-2.06%
Revenue (YoY)
-
Earnings (YoY)
-
PROS
- Healthy ROCE of 21.2%.
- Compounding revenue at 10.5% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Earnings shrank at -2.1% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Ad space
Quarterly Results
Figures in INR.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 349.40 Cr | 375.76 Cr | 336.69 Cr | 331.46 Cr | 397.58 Cr |
| Cost of Revenue | - | 243.50 Cr | 277.14 Cr | 233.45 Cr | 228.34 Cr | 250.96 Cr |
| Gross Profit | - | 105.89 Cr | 98.62 Cr | 103.24 Cr | 103.12 Cr | 146.63 Cr |
| Operating Expenses | - | 77.96 Cr | 71.28 Cr | 74.65 Cr | 71.85 Cr | 105.97 Cr |
| Operating Income | - | 27.93 Cr | 27.34 Cr | 28.59 Cr | 31.26 Cr | 40.66 Cr |
| EBITDA | - | 39.39 Cr | 41.25 Cr | 50.96 Cr | 42.02 Cr | 61.39 Cr |
| Interest Expense | - | 4.38 Cr | 3.65 Cr | 2.96 Cr | 2.20 Cr | 2.39 Cr |
| Pretax Income | - | 24.48 Cr | 26.33 Cr | 35.98 Cr | 27.55 Cr | 44.99 Cr |
| Tax Provision | - | 7.72 Cr | 7.17 Cr | 10.68 Cr | 5.33 Cr | 10.25 Cr |
| Net Income | - | 16.75 Cr | 19.16 Cr | 25.30 Cr | 22.22 Cr | 34.74 Cr |
| Diluted EPS | - | 3.23 | 3.70 | 4.88 | 4.28 | 6.70 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 1,069.27 Cr | 1,113.20 Cr | 1,392.36 Cr | 1,441.50 Cr |
| Cost of Revenue | - | 713.57 Cr | 783.65 Cr | 1,030.14 Cr | 989.89 Cr |
| Gross Profit | - | 355.70 Cr | 329.55 Cr | 362.22 Cr | 451.60 Cr |
| Operating Expenses | - | 212.27 Cr | 247.14 Cr | 279.03 Cr | 323.75 Cr |
| Operating Income | - | 143.43 Cr | 82.41 Cr | 83.19 Cr | 127.85 Cr |
| EBITDA | - | 165.28 Cr | 120.85 Cr | 135.15 Cr | 195.62 Cr |
| Interest Expense | - | 4.53 Cr | 14.80 Cr | 17.32 Cr | 11.21 Cr |
| Pretax Income | - | 145.51 Cr | 74.52 Cr | 76.25 Cr | 134.85 Cr |
| Tax Provision | - | 37.58 Cr | 20.64 Cr | 22.18 Cr | 33.44 Cr |
| Net Income | - | 107.94 Cr | 53.88 Cr | 54.06 Cr | 101.41 Cr |
| Diluted EPS | - | 20.82 | 10.39 | 10.43 | 19.56 |
Compounded Sales Growth
| 5 Years: | 10.47% |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | -2.06% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +30.88% |
| 6 Months: | +19.78% |
| 3 Months: | +29.81% |
| 1 Month: | +19.18% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 803.44 Cr | 922.05 Cr | 998.85 Cr | 986.49 Cr |
| Current Assets | - | 322.51 Cr | 426.27 Cr | 508.38 Cr | 495.39 Cr |
| Cash & Equivalents | - | 15.27 Cr | 15.19 Cr | 26.54 Cr | 31.83 Cr |
| Inventory | - | 105.09 Cr | 125.03 Cr | 137.78 Cr | 128.18 Cr |
| Receivables | - | 137.06 Cr | 203.03 Cr | 254.04 Cr | 244.49 Cr |
| Total Liabilities | - | 327.43 Cr | 400.31 Cr | 445.67 Cr | 365.50 Cr |
| Current Liabilities | - | 179.97 Cr | 272.20 Cr | 350.81 Cr | 298.10 Cr |
| Long Term Debt | - | 124.76 Cr | 93.56 Cr | 62.36 Cr | 31.65 Cr |
| Total Debt | - | 151.79 Cr | 188.35 Cr | 189.34 Cr | 96.39 Cr |
| Total Equity | - | 476.01 Cr | 521.74 Cr | 553.18 Cr | 620.99 Cr |
| Shares Outstanding | - | 5.18 Cr | 5.18 Cr | 5.18 Cr | 5.18 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 121.36 Cr | 40.21 Cr | 84.72 Cr | 203.44 Cr |
| Investing Cash Flow | - | -179.34 Cr | -19.64 Cr | -28.75 Cr | -57.41 Cr |
| Financing Cash Flow | - | 70.78 Cr | -12.99 Cr | -44.49 Cr | -140.89 Cr |
| Capital Expenditure | - | -186.99 Cr | -27.77 Cr | -49.95 Cr | -44.47 Cr |
| Free Cash Flow | - | -65.63 Cr | 12.44 Cr | 34.77 Cr | 158.97 Cr |
| Net Change in Cash | - | 12.80 Cr | 7.59 Cr | 11.49 Cr | 5.15 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 33.3% | 29.6% | 26.0% | 31.3% |
| Operating Margin % | - | 13.4% | 7.4% | 6.0% | 8.9% |
| Net Margin % | - | 10.1% | 4.8% | 3.9% | 7.0% |
| ROE % | - | 22.7% | 10.3% | 9.8% | 16.3% |
| ROCE % | - | 23.0% | 12.7% | 12.8% | 18.6% |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for APCOTEXIND
No recent headlines available.